🔗 Share this article

An underground market for unlicensed weight-loss medications is being driven by TikTok fitness influencers and vendors on messaging platforms, according to recent findings.

Investigational Drug Gaining Popularity Online

Retatrutide, which is still in clinical trials, is being advertised by social media influencers for its alleged weight-reducing effects. Followers are urged to contact these profiles directly for supplier links, while also receiving discount codes.

Active Trade on Messaging Platforms

Additionally, a flourishing market exists on messaging services, where communities with numerous of members share “before and after” photos, injection guides and claims of rapid UK delivery. Vendors promote the substance there before directing buyers to other platforms for purchases.

Understanding Retatrutide

Retatrutide is an experimental injection developed by US drugmaker Eli Lilly. The drug affects three gut hormones – glucagon-like peptide-1, glucose-dependent insulinotropic polypeptide and pancreatic hormone. Early trials suggest it could assist patients reduce up to a quarter of their body weight. Nicknamed the “triple G”, the drug is being promoted online as the next Ozempic.

Healthcare Professionals Express Worries

However, physicians and chemists have cautions that the distribution of what is still an unlicensed drug in the United Kingdom is worrisome and could result in individuals injecting products of uncertain source.

Several experts stated the popularity for the experimental drug could be connected to the increasing cost of licensed slimming treatments such as Mounjaro.

Regulatory Position and Enforcement

Selling retatrutide on social media or messaging apps is illegal in the United Kingdom, as it is an unapproved drug that cannot be promoted or distributed for human use under the British medical regulations.

Several influencers attempt to sidestep the regulations by referring to the drug as a “research chemical” or citing it as “not for human consumption”. The substance is not a controlled drug, but advertising and distribution can still violate medicines, advertising, and consumer regulations, potentially leading to fines, legal action or imprisonment.

Platform Reaction and Material Removal

According to TikTok, the platform has taken down violative content and banned associated hashtags and query recommendations. The company stated it was committed to maintaining the service safe and investing in enhancing compliance measures.

Digital Trading Activities

Research also discovered groups with up to nine thousand members selling retatrutide using the platform's integrated search feature, which operates like a online catalog. Entering “retatrutide” immediately displays groups with numerous of members, filled with photos of slimming results, positive testimonials and step-by-step guides for mixing or administering at home.

Within moments of joining one community, a vendor posted contact information, where most purchases take place. The seller sent an instruction manual and guaranteed delivery within 48 hours. When asked whether the substance was authentic, one seller said: “You can’t be sure.” Another provided a photo of a alleged laboratory certificate. None inquired about weight, medical conditions or past usage.

Product Information and Pricing

Within these groups, posts show black plastic parcels with postal service labels, stating to include new batches. One communication read: “It took eight of us to load them this morning.”

Buyers can select between powder vials, mixed at home with purified liquid, or pre-filled pens typically priced at £160 for 20mg. When questioned how long a pen should be used, sellers give contradictory answers ranging from a several days to “depends on your body”.

Platform Oversight and Security Measures

A representative for the messaging service stated it actively moderated harmful content on its platform including content that promoted the “misuse of controlled medications”. The organization noted that it eliminated “millions of pieces of harmful content each day”.

Medical Expert Cautions

“People are injecting substances they cannot confirm. Although the science behind retatrutide is valid, these digital versions may not include what they advertise,” stated Jason Murphy, the head of pharmaceutical services at a pharmacy service.

Dr Crystal Wyllie of Asda Online Doctor linked the surge in interest to recent price rises for authorized weight-loss medications such as Mounjaro. “With prices rising, individuals are turning to online platforms. But counterfeit injections are extremely dangerous. You can’t be certain what’s contained or whether the environment they were made in was sterile,” she said.

Her staff has already seen patients harmed by self-injection from unconfirmed suppliers. “We recognize the disappointment, but buying from Telegram or communication platforms is taking chances with your well-being,” said the doctor. “These materials could be impure or incorrectly dosed.”

Manufacturer Position

A representative from the pharmaceutical company said retatrutide was in phase 3 research studies and had not been reviewed or approved by any regulatory agency globally. “Consequently at this point no one can sell [it] for personal consumption,” they said, adding that any product “misleadingly claiming itself as a Lilly experimental substance not yet approved … may expose users to potentially serious health risks”.